Title: Antiviral strategies for hepatitis E virus
Authors: Debing, Yannick
Neyts, Johan # ×
Issue Date: Feb-2014
Publisher: Elsevier/North-Holland
Series Title: Antiviral Research vol:102 pages:106-118
Article number: S0166-3542(13)00374-4
Abstract: The hepatitis E virus is a common cause of acute hepatitis. Contrary to hepatitis B and C, hepatitis E is mostly a mild infection, although it has a high mortality in pregnant women and can evolve to chronicity in immunocompromised patients. Ribavirin and pegylated interferon-α are the only available therapies, but both have side effects that are not acceptable for prophylaxis or treatment of mild infections. In addition, these drugs cannot be used for all patient types (e.g. in case of pregnancy, specific organ transplants or co-morbidities) and in resource-poor settings. Hence there is an urgent need for better antiviral treatments that are efficacious and safe, also during pregnancy. In this review, a concise introduction to the virus and disease is provided, followed by a discussion of the available assay systems and potential molecular targets (viral proteins and host factors) for the development of inhibitors of HEV replication. Finally, directions for future research are presented.
ISSN: 0166-3542
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Laboratory of Virology and Chemotherapy (Rega Institute)
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
Antiviral strategies for HEV.pdfOA article Published 2059KbAdobe PDFView/Open


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science